Pinealon (Peptide) – Product Details

Pinealon is a synthetic tripeptide or peptide that is composed of three amino acids. Pinealon has been researched for its potential neuroprotective and cognitive-enhancing properties.

Several studies claimed Pinealon reverses the effects of aging, especially in the central nervous system. Additionally, it might aid in the treatment of cognitive function issues brought on by conditions like Alzheimer’s disease and memory loss due to traumatic brain injuries.

It’s crucial to remember that, in contrast to more well-established treatments, there may not be as much scientific evidence for Pinealon’s safety and efficacy, despite some studies and anecdotal accounts to the contrary. In general, peptide-based compounds are still being studied, thus care should be used while deciding whether to employ them.

It is available in powder form 20mg

What is Pinealon?  

• CAS Number: 10273502 (PUBCHEM CID)
• Molar Mass: 418.40 g/mol
• Chemical Formula: C15H26N6O8
• IUPAC Name: (4S)-4-Amino-5-[[(2S)-3-carboxy-1-[[(1S)-1-carboxy-4-(diaminomethylideneamino)butyl]amino]-1-oxopropan-2-yl]amino]-5-oxopentanoic acid
• Also known by Synonyms as EDR

A synthetic tripeptide with the sequence Glu-Asp-Arg is called Pinealon. It is also known as EDR. [R] It is hypothesized to affect several facets of brain health, possibly affecting elements like neuroplasticity and cognitive function. 

As references would suggest, neuroprotective characteristics of positively charged short peptides rich in arginine have been demonstrated before. In the case of Pinealon, it also has arginine which can be used for studies relating to cognitive functions. 

Because of arginine-rich peptide’s capacity to reduce nerve cell damage and eventually nerve cells will die, these can also mitigate mitochondrial dysfunction and prevent extracellular matrix metalloproteinases from being activated in neuropathology. This can enhance the survival of the neurovascular unit in the brain during different pathological processes. Peptides rich in arginine can have their amino acid residues rearranged to produce peptides with specific neuroprotective properties. [R]

How Pinealon Works?

Pinealon is a bioregulating peptide with potential neuroprotective and cognitive-enhancing properties that have been researched. The precise processes of Pinealon may not be fully understood, and the information that is now accessible may be limited. This is a broad synopsis derived from the information at hand wherein peptides rich in arginine can have their amino acid residues rearranged to produce peptides with specific neuroprotective properties. [R] Since Pinealon has arginine, this composition suggests how arginine potentially affects cognitive function:

1. Production of Nitric Oxide: Arginine is the starting point for the synthesis of nitric oxide (NO), a signaling molecule involved in several physiological functions, including vasodilation (the dilation of blood vessels). Enhanced cerebral blood flow can augment the delivery of oxygen and nutrients, potentially supporting cognitive function. [R]
2. Blood Flow and Oxygenation: Increasing nitric oxide production on research with compounds containing arginine may enhance cerebral blood flow, which is essential for the best possible cognitive function. Brain cells require a sufficient amount of nutrients and oxygen to meet their energetic needs. [R]
3. Regulation of Neurotransmitters: Arginine is a precursor to several neurotransmitters, including nitric oxide, which has neuromodulatory properties. Neurotransmitters are vital for cognitive functions including memory and learning as well as for nerve cell-to-nerve cell transmission. [R]
4. Antioxidant capabilities: Oxidative stress is linked to neurological disorders and cognitive loss. Arginine possesses these capabilities. Free radicals are countered by antioxidants, which may shield brain tissue from harm. [R]
5. Stimulation of Growth Hormone: It has been proposed that arginine can induce the release of growth hormone. Growth hormone is involved in many physiological processes, including memory, and its release may have positive effects on cognition. [R]

The potential research uses for Pinealon are listed below:

Potential Research Applications for Pinealon

Pinealon and Anti-Aging Research

In a study that involved 32 test subjects with polymorbidity and organic brain syndrome in remission that suggests a diverse group of participants with multiple health conditions, the study recommends the application of Pinealon and Vesugen for reducing the rate of aging in patients with the organic brain syndrome of vascular and/or traumatic origin. [R]]

In another study of diverse test subject study, involving 110 test subjects from different age groups. The study assessed the efficacy and safety of methods such as dry carbon dioxide baths, hyperbaric oxygen therapy, therapeutic massage, and the use of Oligopeptide preparations, specifically Vezugen and Pinealon. In conclusion, the findings suggest that a combination of Oligopeptide complexes (Vezugen and Pinealon) had a significant positive impact on biological age indicators. [R]

The information for the connection between irisin, a hormone produced by muscles during exercise that promotes fat burning, and geroprotective effects, including the induction of telomere elongation in normal somatic cells. Additionally, peptides such as Lys-Glu, Glu-Asp-Arg, and Ala-Glu-Asp-Gly are highlighted for their role in epigenetic regulation of irisin content. and the potential modulation of aging-related processes. The involvement of Pinealon peptides in the epigenetic regulation of irisin gene expression suggests a role in influencing the production of this hormone with potential implications for health and longevity. [R]

In another study, the use of Pinealon by test subjects of locomotive brigades had positive effects on parameters related to biological age and the effectiveness of adaptive reactions. These results suggest a potential role for Pinealon in promoting the health and professional reliability of individuals engaged in physically and mentally demanding occupations, such as those in locomotive brigades. However, it’s important to note that further research and larger-scale studies may be needed to validate and extend these findings. [R]

Pinealon and Neuroprotective Effects Research

In the study, Vesugen and Pinealon, two short synthetic tripeptides, were evaluated with 18 male and 12 female test subjects ages 41 to 83, were part of the study. Every individual was free of organic brain syndrome and had polymorbidity, or the presence of various medical diseases.

In conclusion, Pinealon and Vesugen appear to have positive effects on anabolic processes, the central nervous system, and vital organs. The study recommends their application in geriatric practice for individuals with the organic brain syndrome of vascular and/or traumatic origin. The observed prooxidant activity and impact on hemopoiesis highlight areas for further investigation and consideration in the clinical use of these peptides. [R]

In a separate review, comparative features of two peptide neuroprotective groups—short peptides (semax, kortagen, pinealon) and polypeptide complexes (cortexin, cerebrolizin)—are included in the review. Data on the clinical use of peptides in the aged and old are presented, together with the cellular and molecular mechanisms behind their neuroprotective effects. [R]

Pinealon and Learning Retention or Memory Improvement Research

The study described investigated the effects of the peptide drug Pinealon (Glu-Asp-Arg) at different doses on the training of rats in the Morris maze and the maintenance of acquired skills after the development of experimental diabetes. The study also examined changes in the subunit composition of NMDA receptors in the hippocampus in these experimental models. The results of this study indicate that pinealon, especially at a particular dosage of 100 ng/kg, may have a neuroprotective effect on cognitive function, as demonstrated by the preservation of learned skills in the context of experimental diabetes and enhanced performance in spatial learning tests. [R]

The EDR peptide has been shown to normalize behavioral responses in animal studies and improve memory in elderly patients. This suggests potential cognitive benefits. [R]

Pinealon and Hyperhomocysteinemia 

An elevated level of the amino acid homocysteine (HC) in the blood is the hallmark of the illness known as hyperhomocysteinemia. Dementia risk is increased by this vitamin deficiency. [R]

In one particular investigation, the effects of pinealon were investigated in pregnant female rats that had been intentionally rendered hyperhomocysteinemic. Beginning in the second trimester, the female rats received methionine supplements, which increased the levels of HC in the blood. Then, for this inquiry, both the experimental mice and the healthy mouse progeny of rats were used. According to analysis, the progeny’s homocysteine levels were unaffected by the peptide. Nevertheless, the rats that had the peptide did show some improvement in their cognitive ability, thus it had some good effects. [R]

Pinealon and Depression

Studies were conducted on isolated brain cell cultures that received the pinealon peptide in vitro. The peptide raised serotonin expression levels in the cell cultures, according to analysis. Using the molecular docking technique, it was found that the peptide regulated the synthesis of the 5-tryptophan hydroxylase enzyme, which is necessary for the synthesis of serotonin. The signaling molecule is also the target of antidepressants and SSRIs (selective serotonin reuptake inhibitors). Serotonin is an essential hormone that helps control mood and overall well-being. The researchers’ report suggests that the peptide may be a type of depression treatment.  [R]

Pinealon and Anti-apoptotic Effects Research 

Research has shown that Pinealon-based peptide treatment affects the levels of the caspase 3 enzyme. An important component of controlled cell death, or apoptosis, is the enzyme caspase 3. Pinealon peptide treatment controlled the levels of this enzyme in experimental rat models of ischemic stroke, preventing the process of cellular death. Consequently, the effects of hypoxia during the stroke were mitigated. [R]

Peptides Glu-Asp-Arg and Lys-Glu did not affect the expression of the apoptosis marker AIF (Apoptosis-Inducing Factor). This suggests that these peptides did not influence programmed cell death in the pineal gland culture.[R]

Lastly, reducing the impacts of the caspase 3 enzyme was beneficial to skin cells. The peptide accelerates the regeneration process by reducing cellular death and increasing cell proliferation in both young and old test subjects. [R]

Pinealon and Sleep Regulation 

A study suggests that pinealon may be able to help control the dysfunction brought on by shift work, which disrupts regular sleep cycles. The peptide seems to restore baseline pineal gland function in the context of circadian rhythm disruption, hence potentially enhancing blood pressure, mood, depression, and sleep quality. [R]

Pinealon and Alzheimer’s Disease 

The EDR peptide interferes with the elimination of dendritic spines in neuronal cultures obtained from mice with Alzheimer’s (AD) and Huntington’s diseases. This suggests a potential impact on the structural integrity of neurons in neurodegenerative conditions. The EDR peptide is suggested to have potential therapeutic implications in Alzheimer’s disease, potentially influencing multiple molecular pathways involved in the pathology of the condition. [R]

When peptide EDR (200 ng/ml) was added to mice hippocampus neurons in primary culture, amyloid synaptotoxicity (a model of Alzheimer’s disease) increased the number of mushroom spines by 71%, bringing this metric back to its typical range. In the same circumstances, a 20% increase in mushroom spines was seen in hippocampus neurons when exposed to tripeptide KED (200 ng/ml). It is possible to suggest tripeptide EDR for additional experimental research as a potential neuroprotective medication for Alzheimer’s disease therapy and prevention. [R]

Pinealon and Skin Regeneration Research

The impact of bioregulatory tripeptides T-32 (Glu-Asp-Ala), T-33 (Glu-Asp-Arg), T-34 (Glu-Asp-Gly), T-36 (Glu-Asp-Pro), and T-38 (Lys-Glu-Asp) on the skin cell culture of juvenile and adult rats can stimulate cell proliferation in skin tissues, with age-dependent effects observed. Specifically, T-38 showed a marked stimulatory effect in skin explants from old rats. The potential of these tripeptides to enhance regenerative processes in the skin, especially in the context of age-related pathology, highlights their significance for further investigation and potential therapeutic applications. [R]

Pinealon and Gene Activity Expression 

One study provides evidence that short biologically active peptides, including epithalon, pinealon, and testagen, can penetrate cells, including the nucleus, and interact with nucleic acids. The site-specific interactions with DNA, as observed in the study, suggest a potential role in epigenetic control and gene regulation, highlighting the importance of these peptides in cellular and genetic processes. [R]

Pinealon and Pineal Gland Function

According to one study, some short peptides, specifically Lys-Glu-Asp and Ala-Glu-Asp-Gly, can affect how signaling molecules are expressed in pineal gland cultures. It was discovered that these peptides promoted cell division while not affect apoptosis. Furthermore, Ala-Glu-Asp-Gly demonstrated selectivity in inducing the transcription factor CGRP’s production. These peptides, particularly Ala-Glu-Asp-Gly, have tissue-specific effects that point to their potential use in supporting the molecular restoration of pineal gland functioning. [R]

Conclusion

Pinealon, a synthetic tripeptide composed of Glu-Asp-Arg, has garnered attention for its potential neuroprotective and cognitive-enhancing properties. While various studies suggest its positive impact on aging, cognitive function, and several health conditions, it’s important to approach its use with caution due to the ongoing research and the limited scientific evidence available.

Pinealon contains arginine, a positively charged peptide known for neuroprotective effects. Arginine-rich peptides may mitigate nerve cell damage, prevent mitochondrial dysfunction, and inhibit extracellular matrix metalloproteinases in neuropathology.

Possible research applications can be epigenetic studies or anti-aging properties, neuroprotective effects, learning Retention or memory improvement, hyperhomocysteinemia, depression, anti-apoptotic effect, sleep regulation, Alzheimer’s disease, skin regeneration, gene activity expression, and normal pineal gland function.

BehemothLabz Disclaimer

Please make sure you go through the Terms and Conditions, and please familiarize yourself with it as it is important. Please research the scientific uses of this product before making any purchases. Make note that the packaging and labels of the product may differ from those shown on the website.

Buying the product means you agree with our Terms and Conditions. You can contact our awesome customer service team at [email protected] if you are not fully satisfied with the product. Customer satisfaction is our number one priority!

ATTENTION: All BehemothLabz products are strictly for LABORATORY AND RESEARCH PURPOSES ONLY. They are not to be used for any human or veterinary purposes.

 

Strength	20mg